InVivo Therapeutics Holdings Corporation NVIV
0.32 0.00 0.00%
At close · Feb 12
52-week range unavailable
- Open
- 0.4081
- Prev close
- 0.3207
- Mkt cap
- 995.92K
- Vol
- 1.61M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.301
- High
- 0.409
- Forward P/E
- -0.03
- Beta
- 0.66
- Short ratio
- 0.91
- Inst. own
- 3.44%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 14, 2024
- 50-d avg
- 0.605553
- 200-d avg
- 0.98865
- 1y target
- 0.00
MAX chart
Chart tools
Chart is warming up
The all-time price history for NVIV has not been loaded yet. Try again in a moment.
Altman Z-Score
-38.64 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
P/E -0.4×
P/S 0.0×
P/B 0.2×
P/FCF -0.3×
EV/EBITDA 1.2×
EV/Sales 0.0×
FCF Yield -294.7%
Gross Margin 0.0%
Operating Margin 0.0%
Net Margin 0.0%
ROE -64.6%
ROIC -63.6%
ROA -54.1%
Revenue 0.0%
Operating Income -7.6%
EPS (diluted) 11.4%
Free Cash Flow -19.2%
Current Ratio 7.1×
Quick Ratio 7.1×
Debt / Equity 0.1×
Net Debt / EBITDA 1.6×
Interest Coverage -70.5×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2022-12-31